Digital, remote cardiovascular prevention versus traditional in-person care
Official title: Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model
Run by Maria Cecilia Hospital · NCT07608926 · Data updated 2026-11-12
A remote, app-guided prevention program for adults 40–75 with cardiovascular risk is compared to standard in-person care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 144 (estimated) |
| Sponsor | Maria Cecilia Hospital Academic / other |
| Locations | 1 site (Cotignola, Ravenna) |
| Status | Recruiting |
| Started | May 28, 2025 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | May 27, 2026 |
| Trial ID | NCT07608926 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–75 with hypertension, dyslipidemia, hyperglycemia or type 2 diabetes (not requiring insulin), obesity/overweight, and/or active smoking who are willing to participate in 24 months of follow-up.
✕Probably not a fit
Patients unable or unwilling to use digital tools or with advanced cardiovascular disease or significant comorbidities may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests whether a digital prevention pathway delivered through a mobile application can match or improve outcomes compared with traditional in-person care for people at risk of cardiovascular disease. Eligible participants have several risk factors such as hypertension, high blood sugar, dyslipidemia, smoking, and overweight status, and must be willing to follow up for 24 months. The intervention consists of patient-facing recommendations delivered through the app, with the goal of reducing cardiovascular risk factors and events. The study is conducted at Maria Cecilia Hospital in Cotignola, Ravenna, led by Maria Cecilia Hospital, with no listed collaborators. Outcomes and feasibility will be assessed over two years to determine the viability of remote prevention in this population.
Why it matters
Potential benefit: If successful, the remote prevention pathway could improve risk factor control and accessibility of care for people at cardiovascular risk.
How similar studies have gone: Previous work in digital health for cardiovascular risk reduction has shown promise, but results vary by setting and integration with standard care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 40 and 75 years * hypertension * hyperglycaemia * type 2 diabetes not requiring insulin therapy * dyslipidaemia * active smoking * overweight/grade I obesity * Willingness to participate in follow-up visits over 24 months Exclusion Criteria: * previous myocardial infarction * stroke * transient ischemic attack * coronary artery diseas * peripheral arterial occlusive disease * heart failure * Type 1 or type 2 diabetes mellitus on insulin therapy * Advanced chronic kidney disease (eGFR \< 30 mL/min/1.73 m²) * Active cancer disease * Severe obesity * Inability to use digital tools * Pregnancy
Where it's running
-
Maria Cecilia Hospital
Cotignola, Ravenna, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Air filters at home to see if breathing cleaner air helps heart health in obesity
This study tests whether portable air filtration systems can improve cardiovascular risk factors in adults with obesity and high blood pressure.
-
Bringing preventive cardiovascular care to Indigenous and remote communities
This project tests a mobile health unit to screen and provide culturally safe cardiovascular and metabolic care for Indigenous and remote communities in Canada.
-
Breast Artery Calcification and Heart Health in Women
This study tests whether a breast artery calcification finding on a mammogram is linked to different cardiovascular markers in women 55–65 who do or do not have BAC.
-
Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis
This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.
-
Work-Related Frustration and Higher Blood Pressure Risk in Everyday Adults
This observational study tests whether stress and frustration at work relate to blood pressure patterns that signal higher cardiovascular risk among adults aged 40–65 who are working and have no prior cardiovascular disease or blood pressure treatment.
-
Cardiac risk test using breast cancer radiotherapy scans to guide decisions
This study tests whether checking coronary artery calcium on planning CT scans can help patients with breast cancer make informed heart-risk decisions during radiotherapy planning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.